Anecortave Acetate (BioDeep_00000664550)
代谢物信息卡片
化学式: C23H30O5 (386.209313)
中文名称: Anecortave醋酸盐
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CC(=O)OCC(=O)C1(CCC2C1(CC=C3C2CCC4=CC(=O)CCC43C)C)O
InChI: InChI=1S/C23H30O5/c1-14(24)28-13-20(26)23(27)11-8-19-17-5-4-15-12-16(25)6-9-21(15,2)18(17)7-10-22(19,23)3/h7,12,17,19,27H,4-6,8-11,13H2,1-3H3/t17-,19+,21+,22+,23+/m1/s1
描述信息
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone
C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
同义名列表
1 个代谢物同义名
数据库引用编号
6 个数据库交叉引用编号
- ChEBI: CHEBI:31215
- KEGGdrug: D01733
- PubChem: 111332
- DrugBank: DB05288
- ChEMBL: CHEMBL2106613
- CAS: 7753-60-8
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Erica K M Reeves, Eric P Hoffman, Kanneboyina Nagaraju, Jesse M Damsker, John M McCall. VBP15: preclinical characterization of a novel anti-inflammatory delta 9,11 steroid.
Bioorganic & medicinal chemistry.
2013 Apr; 21(8):2241-2249. doi:
10.1016/j.bmc.2013.02.009. [PMID: 23498916] - Hui Wang, Ao Li, Xiao-Ping Dong, Xiao-Yu Xu. [Screening of anti-tumor parts from the seeds of Livistona chinensis and its anti-angiogenesis effect].
Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials.
2008 May; 31(5):718-22. doi:
". [PMID: 18826151] - David C Dahlin, Mohamad H Rahimy. Pharmacokinetics and metabolism of anecortave acetate in animals and humans.
Survey of ophthalmology.
2007 Jan; 52 Suppl 1(?):S49-61. doi:
10.1016/j.survophthal.2006.11.002. [PMID: 17240257] - M Vaughn Emerson, Andreas K Lauer. Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.
2007; 21(4):245-57. doi:
10.2165/00063030-200721040-00005. [PMID: 17628122] - Albert J Augustin, Donald J D'Amico, William F Mieler, Cary Schneebaum, Cliff Beasley. Safety of posterior juxtascleral depot administration of the angiostatic cortisene anecortave acetate for treatment of subfoveal choroidal neovascularization in patients with age-related macular degeneration.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie.
2005 Jan; 243(1):9-12. doi:
10.1007/s00417-004-0961-4. [PMID: 15290154] - Donald J D'Amico, Morton F Goldberg, Henry Hudson, Janice A Jerdan, D Scott Krueger, Susan P Luna, Stella M Robertson, Stephen Russell, Lawrence Singerman, Jason S Slakter, Lawrence Yannuzzi, Patricia Zilliox. Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes.
Ophthalmology.
2003 Dec; 110(12):2372-83; discussin 2384. doi:
10.1016/j.ophtha.2003.08.020. [PMID: 14644721]